Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-12-24
1993-10-12
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544 52, A61K 3154, C07D27916
Patent
active
052525716
ABSTRACT:
1,4-Benzothiazine-2-acetic acid derivatives having an excellent aldose reductase inhibitory activity which are useful for the prevention and treatment of diabetic complications, such as diabetic cataract, retinopathy, nephropathy and neuropathy.
REFERENCES:
patent: 3503965 (1990-03-01), Langis
patent: 3910904 (1975-10-01), Worley
Chemical And Pharmaceutical Bulletin, vol. 20, No. 4, Apr., 1972, pp. 832-834, Y. Maki,et al., "Further Studies on the Reaction of 2-Aminothiophenol with Dimethyl Acetylenedicarboxylate".
Chemical And Pharmaceutical Bulletin, vol. 24, No. 9, pp. 2250-2253, 1976, Y. Maki, et al., "Facile Thermal Dimerization of a Photochemically Isomerized Olefin".
Aotsuka Tomoji
Hosono Hiroshi
Kobayashi Fujio
Kurihara Toshio
Matsui Tetsuo
Ford John M.
Sapporo Breweries Limited
LandOfFree
1,4-benzothiazine-2-acetic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,4-benzothiazine-2-acetic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,4-benzothiazine-2-acetic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1904625